Yorktown Management & Research Co Inc continued to hold its position in Medidata Solutions, Inc. (NASDAQ:MDSO) during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 4,600 shares of the company’s stock at the end of the second quarter. Yorktown Management & Research Co Inc’s holdings in Medidata Solutions were worth $360,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Amalgamated Bank lifted its holdings in shares of Medidata Solutions by 11.3% during the 2nd quarter. Amalgamated Bank now owns 8,089 shares of the company’s stock worth $633,000 after acquiring an additional 818 shares during the last quarter. Nationwide Fund Advisors lifted its holdings in shares of Medidata Solutions by 16.3% during the 2nd quarter. Nationwide Fund Advisors now owns 738,705 shares of the company’s stock worth $57,767,000 after acquiring an additional 103,391 shares during the last quarter. TIAA CREF Investment Management LLC lifted its holdings in shares of Medidata Solutions by 2.6% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 153,565 shares of the company’s stock worth $12,009,000 after acquiring an additional 3,925 shares during the last quarter. Teachers Advisors LLC lifted its holdings in shares of Medidata Solutions by 3.2% during the 2nd quarter. Teachers Advisors LLC now owns 383,530 shares of the company’s stock worth $29,992,000 after acquiring an additional 11,976 shares during the last quarter. Finally, Riverhead Capital Management LLC lifted its holdings in shares of Medidata Solutions by 75.7% during the 2nd quarter. Riverhead Capital Management LLC now owns 5,096 shares of the company’s stock worth $398,000 after acquiring an additional 2,196 shares during the last quarter. Hedge funds and other institutional investors own 97.53% of the company’s stock.

A number of analysts have recently issued reports on the stock. Jefferies Group LLC reaffirmed a “hold” rating and set a $78.00 price objective on shares of Medidata Solutions in a report on Tuesday, August 22nd. Morgan Stanley set a $74.00 price objective on shares of Medidata Solutions and gave the stock a “buy” rating in a report on Wednesday, June 14th. Needham & Company LLC reaffirmed a “buy” rating and set a $90.00 price objective (up from $75.00) on shares of Medidata Solutions in a report on Friday, July 21st. BidaskClub downgraded shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, June 14th. Finally, Citigroup Inc. reissued a “buy” rating and issued a $94.00 price target (up from $77.00) on shares of Medidata Solutions in a research note on Monday, July 10th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $82.91.

Medidata Solutions, Inc. (MDSO) traded down 0.18% during trading on Friday, hitting $75.86. 1,487,628 shares of the company’s stock were exchanged. The firm has a 50 day moving average price of $74.69 and a 200 day moving average price of $69.86. Medidata Solutions, Inc. has a 52-week low of $46.10 and a 52-week high of $85.92. The company has a market cap of $4.30 billion, a price-to-earnings ratio of 122.55 and a beta of 1.81.

Medidata Solutions (NASDAQ:MDSO) last released its earnings results on Tuesday, July 18th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.28 by $0.03. The firm had revenue of $137.41 million during the quarter, compared to analyst estimates of $134.28 million. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. The business’s revenue was up 19.9% on a year-over-year basis. During the same quarter last year, the business earned $0.24 EPS. On average, equities research analysts predict that Medidata Solutions, Inc. will post $1.28 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Yorktown Management & Research Co Inc Has $360,000 Stake in Medidata Solutions, Inc. (MDSO)” was first published by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/09/16/yorktown-management-research-co-inc-has-360000-stake-in-medidata-solutions-inc-mdso.html.

In other news, COO Michael L. Capone sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $74.53, for a total value of $372,650.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 5.80% of the stock is currently owned by company insiders.

Medidata Solutions Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions, Inc. (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.